311 related articles for article (PubMed ID: 12948801)
61. Effect of hypnotic drugs on sleep architecture.
Terzano MG; Parrino L
Pol J Pharmacol; 1994; 46(5):487-90. PubMed ID: 7894540
[TBL] [Abstract][Full Text] [Related]
62. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping.
Saletu-Zyhlarz G; Saletu B; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):117-29. PubMed ID: 9313244
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of automated and semi-automated scoring of polysomnographic recordings from a clinical trial using zolpidem in the treatment of insomnia.
Svetnik V; Ma J; Soper KA; Doran S; Renger JJ; Deacon S; Koblan KS
Sleep; 2007 Nov; 30(11):1562-74. PubMed ID: 18041489
[TBL] [Abstract][Full Text] [Related]
64. The exploratory power of sleep effort, dysfunctional beliefs and arousal for insomnia severity and polysomnography-determined sleep.
Hertenstein E; Nissen C; Riemann D; Feige B; Baglioni C; Spiegelhalder K
J Sleep Res; 2015 Aug; 24(4):399-406. PubMed ID: 25773981
[TBL] [Abstract][Full Text] [Related]
65. [Contribution of zolpidem in the management of sleep disorders].
Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
[TBL] [Abstract][Full Text] [Related]
66. Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea.
Kryger M; Wang-Weigand S; Roth T
Sleep Breath; 2007 Sep; 11(3):159-64. PubMed ID: 17294232
[TBL] [Abstract][Full Text] [Related]
67. Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers.
Paterson LM; Nutt DJ; Ivarsson M; Hutson PH; Wilson SJ
J Psychopharmacol; 2009 Jul; 23(5):487-94. PubMed ID: 19351801
[TBL] [Abstract][Full Text] [Related]
68. Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.
Walsh JK; Mayleben D; Guico-Pabia C; Vandormael K; Martinez R; Deacon S
Sleep Med; 2008 May; 9(4):393-402. PubMed ID: 17765013
[TBL] [Abstract][Full Text] [Related]
69. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial.
Morin CM; Koetter U; Bastien C; Ware JC; Wooten V
Sleep; 2005 Nov; 28(11):1465-71. PubMed ID: 16335333
[TBL] [Abstract][Full Text] [Related]
70. An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.
Rosenberg R; Caron J; Roth T; Amato D
Sleep Med; 2005 Jan; 6(1):15-22. PubMed ID: 15680290
[TBL] [Abstract][Full Text] [Related]
71. Sleep characteristics of menopausal insomnia: a polysomnographic study.
Terashima K; Mikami A; Tachibana N; Kumano-Go T; Teshima Y; Sugita Y; Takeda M
Psychiatry Clin Neurosci; 2004 Apr; 58(2):179-85. PubMed ID: 15009824
[TBL] [Abstract][Full Text] [Related]
72. The cyclic alternating pattern decreases as a consequence of total sleep deprivation and correlates with EEG arousals.
De Gennaro L; Ferrara M; Spadini V; Curcio G; Cristiani R; Bertini M
Neuropsychobiology; 2002; 45(2):95-8. PubMed ID: 11893866
[TBL] [Abstract][Full Text] [Related]
73. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
74. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.
Sivertsen B; Omvik S; Pallesen S; Bjorvatn B; Havik OE; Kvale G; Nielsen GH; Nordhus IH
JAMA; 2006 Jun; 295(24):2851-8. PubMed ID: 16804151
[TBL] [Abstract][Full Text] [Related]
75. Dissociation of periodic leg movements from arousals in restless legs syndrome.
Manconi M; Ferri R; Zucconi M; Bassetti CL; Fulda S; Aricò D; Ferini-Strambi L
Ann Neurol; 2012 Jun; 71(6):834-44. PubMed ID: 22718547
[TBL] [Abstract][Full Text] [Related]
76. Menstrual Cycle-Related Variation in Physiological Sleep in Women in the Early Menopausal Transition.
de Zambotti M; Willoughby AR; Sassoon SA; Colrain IM; Baker FC
J Clin Endocrinol Metab; 2015 Aug; 100(8):2918-26. PubMed ID: 26079775
[TBL] [Abstract][Full Text] [Related]
77. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
Monti JM; Attali P; Monti D; Zipfel A; de la Giclais B; Morselli PL
Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
[TBL] [Abstract][Full Text] [Related]
78. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
Roger M; Attali P; Coquelin JP
Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
[TBL] [Abstract][Full Text] [Related]
79. CAP components and EEG synchronization in the first 3 sleep cycles.
Terzano MG; Parrino L; Boselli M; Smerieri A; Spaggiari MC
Clin Neurophysiol; 2000 Feb; 111(2):283-90. PubMed ID: 10680563
[TBL] [Abstract][Full Text] [Related]
80. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.
Scharf M; Rogowski R; Hull S; Cohn M; Mayleben D; Feldman N; Ereshefsky L; Lankford A; Roth T
J Clin Psychiatry; 2008 Oct; 69(10):1557-64. PubMed ID: 19192438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
